このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Tri Chemical Laboratories マネジメント

マネジメント基準チェック /14

Tri Chemical Laboratories'の CEO はKiyoshi Tazukeで、 Apr2014年に任命され、の在任期間は 10.33年です。は、会社の株式の0.94%を直接所有しており、その価値は¥ 1.07B 。経営陣と取締役会の平均在任期間はそれぞれ6.6年と7.3年です。

主要情報

Kiyoshi Tazuke

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	10.4yrs
CEOの所有権	0.9%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	7.4yrs

経営陣の近況

Recent updates

Tri Chemical Laboratories' (TSE:4369) Weak Earnings May Only Reveal A Part Of The Whole Picture

Sep 06

Tri Chemical Laboratories Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Sep 03

Tri Chemical Laboratories Inc.'s (TSE:4369) 37% Cheaper Price Remains In Tune With Earnings

Aug 05

Is Tri Chemical Laboratories (TSE:4369) A Risky Investment?

May 01

The Returns On Capital At Tri Chemical Laboratories (TSE:4369) Don't Inspire Confidence

Apr 01

Investors Appear Satisfied With Tri Chemical Laboratories Inc.'s (TSE:4369) Prospects As Shares Rocket 30%

Feb 29

Estimating The Intrinsic Value Of Tri Chemical Laboratories Inc. (TSE:4369)

Feb 28

CEO（最高経営責任者

Kiyoshi Tazuke (60 yo)

10.4yrs

在職期間

Mr. Kiyoshi Tazuke has been the President of Tri Chemical Laboratories Inc since April 2014 and also serves as its CEO since April 2022 and serves as its Representative Director and serves as its Manager s...

取締役

名称	ポジション	在職期間	報酬	所有権
Kiyoshi Tazuke	President	17.4yrs	データなし	0.94% ¥ 1.1b
Hironobu Ohsugi	Executive Officer of Technology Department & Director	7.4yrs	データなし	0.35% ¥ 424.2m
Yoshihide Suzuki	Executive Officer of Administration Department & Director	no data	データなし	0.42% ¥ 498.8m
Jumpei Takenaka	Chairman of the Board	23.4yrs	データなし	12.81% ¥ 15.4b
Motoharu Takamatsu	Full-Time Audit & Supervisory Board Member	6.4yrs	データなし	0.30% ¥ 358.0m
Hitoshi Iida	Independent External Director	no data	データなし	データなし
Toshihisa Hashimoto	External Independent Outside Director	1.4yrs	データなし	データなし
Kyoko Kato	Independent External Director	no data	データなし	データなし
Koji Sakakura	External Auditor	no data	データなし	データなし
Young Gil Chung	External Auditor	no data	データなし	データなし

7.4yrs

平均在職期間

60yo

平均年齢

経験豊富なボード: 4369の取締役会は経験豊富であると考えられます ( 7.3年の平均在任期間)。

Tri Chemical Laboratories マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Tri Chemical Laboratories Inc., Annual General Meeting, Apr 25, 2024

No independent directors

No independent directors

Recent updates

Tri Chemical Laboratories Inc. to Report Q3, 2025 Results on Nov 29, 2024

Investor sentiment deteriorates as stock falls 19%

Tri Chemical Laboratories' (TSE:4369) Weak Earnings May Only Reveal A Part Of The Whole Picture

Tri Chemical Laboratories Inc. Provides Consolidated Earnings Guidance for the Full Fiscal Year Ending January 31, 2025

Tri Chemical Laboratories Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Second quarter 2025 earnings: EPS and revenues exceed analyst expectations

Tri Chemical Laboratories Inc.'s (TSE:4369) 37% Cheaper Price Remains In Tune With Earnings

Investor sentiment deteriorates as stock falls 24%

New major risk - Share price stability

Price target decreased by 10% to JP¥6,025

Tri Chemical Laboratories Inc. to Report Q2, 2025 Results on Aug 30, 2024

Price target increased by 12% to JP¥6,700

Tri Chemical Laboratories Inc. Provides Dividend Guidance for the Fiscal Year Ending January 31, 2025

First quarter 2025 earnings released: EPS: JP¥24.99 (vs JP¥30.53 in 1Q 2024)

Is Tri Chemical Laboratories (TSE:4369) A Risky Investment?

Tri Chemical Laboratories Inc. to Report Q1, 2025 Results on May 31, 2024

The Returns On Capital At Tri Chemical Laboratories (TSE:4369) Don't Inspire Confidence

Now 22% undervalued

Full year 2024 earnings: Revenues and EPS in line with analyst expectations

Tri Chemical Laboratories Inc., Annual General Meeting, Apr 25, 2024

Now 20% overvalued after recent price rise

Price target increased by 9.5% to JP¥5,200

Investors Appear Satisfied With Tri Chemical Laboratories Inc.'s (TSE:4369) Prospects As Shares Rocket 30%

Estimating The Intrinsic Value Of Tri Chemical Laboratories Inc. (TSE:4369)

Tri Chemical Laboratories Inc. to Report Fiscal Year 2024 Results on Mar 15, 2024

Upcoming dividend of JP¥30.00 per share at 0.8% yield

Now 21% overvalued after recent price rise

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 18% to JP¥4,500

Now 21% undervalued

New minor risk - Share price stability

Now 22% undervalued

Tri Chemical Laboratories Inc. to Report Q3, 2024 Results on Nov 30, 2023

Price target increased by 7.0% to JP¥3,800

Consensus revenue estimates fall by 16%

Tri Chemical Laboratories Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending January 31, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Tri Chemical Laboratories Inc. to Report Q2, 2024 Results on Aug 31, 2023

Consensus EPS estimates fall by 13%

Tri Chemical Laboratories Inc. Provides Consolidated Earnings Guidance for the First Half and Fiscal Year Ending January 31, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 22% undervalued after recent price drop

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment deteriorates as stock falls 19%

Price target decreased by 13% to JP¥3,333

Upcoming dividend of JP¥22.00 per share

Tri Chemical Laboratories Inc. to Report Fiscal Year 2023 Results on Mar 15, 2023

Tri Chemical Laboratories Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending January 31, 2023

Now 21% undervalued

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Price target decreased to JP¥3,750

No independent directors

Price target decreased to JP¥3,750

Investor sentiment improved over the past week

Tri Chemical Laboratories Inc. to Report Q3, 2023 Results on Nov 30, 2022

Tri Chemical Laboratories Inc. Provides Dividend Guidance for the Fiscal Year Ending January 31, 2023

Tri Chemical Laboratories Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending January 31, 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations

Tri Chemical Laboratories Inc. Provides Dividend Guidance for the Fiscal Year Ending January 31, 2023

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improved over the past week

No independent directors

Tri Chemical Laboratories Inc. to Report Q1, 2023 Results on May 31, 2022

Full year 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

Upcoming dividend of JP¥17.00 per share

Tri Chemical Laboratories Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending January 31, 2022

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to JP¥4,200

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

マネジメント基準チェック /14